Clozapine Side Effects: What to Expect and When

Creator: Ryan S. Sultan, MD
Published: 2026-11-12

By Ryan S. Sultan, MD
Psychiatrist · Columbia University Irving Medical Center
Published November 12, 2026 · 5-minute read

Blood counts get most of the attention with clozapine. Constipation and pneumonia deserve as much. In a Finnish study that followed 2,659 people for up to 25 years after starting clozapine, the cumulative incidence at 20 years was 5.3% for ileus, a severe slowing of the bowel, and 29.5% for pneumonia. Both were associated with higher mortality.¹

Most of these effects are predictable in timing and can be monitored.

When each side effect tends to appear

Timing of clozapine's main adverse effects
Period	What to watch for
First doses and dose increases	Low blood pressure on standing, slow heart rate, fainting. The label recommends starting at 12.5 mg once or twice daily for this reason
First 2 months	Fever, myocarditis and pericarditis
First 18 weeks	Highest risk of severe neutropenia
Throughout treatment	Constipation, sedation, drooling, fast heart rate, seizures at higher doses, weight gain, diabetes, pneumonia

Source: Clozaril prescribing information, revised June 2025.²

Constipation can become dangerous

Clozapine has strong anticholinergic effects that slow the gut. The label describes a range from constipation to paralytic ileus, with complications that include fecal impaction, bowel obstruction, and perforation, and states that these reactions have resulted in hospitalization, surgery, and death.² In the Finnish cohort, ileus was associated with 4.5 times the odds of death among clozapine users.¹

Patients' own reports of constipation may not reflect how slow the bowel has become, so the prescriber should ask about the frequency and character of bowel movements frequently. Other anticholinergic medications, including benztropine and diphenhydramine, add to the risk and should be avoided when possible. The label recommends screening for constipation before starting, treating promptly with laxatives, and considering preventive laxatives in high-risk patients.²

Constipation with abdominal pain, swelling, nausea, or vomiting in someone taking clozapine needs prompt medical assessment. The evidence on laxatives and warning signs is on the page about clozapine constipation.

Myocarditis occurs early

An Australian review of 8,000 patients who started clozapine between 1993 and 1999 identified 15 cases of myocarditis and 8 of cardiomyopathy. Every case of myocarditis occurred within three weeks of starting, and five of those patients died.³ The current label states that myocarditis and pericarditis most often present within the first two months, and that cardiomyopathy usually appears later.²

Fever, chest pain, shortness of breath, a racing heart at rest, or flu-like symptoms in the first weeks warrant prompt evaluation. A 2026 international consensus recommended titration schedules slower than those in the product labeling to reduce the risk, and set out minimum screening requirements.⁴ In a review of 512 patients across 21 Japanese hospitals, faster titration, male sex, and concurrent valproate or quetiapine were each associated with a higher risk of fever during clozapine initiation.⁵ Symptoms, timing, and blood test monitoring are covered on the page about clozapine myocarditis.

Weight gain and diabetes

In a five-year naturalistic study of 82 outpatients on clozapine, 36.6% were diagnosed with diabetes, and weight gain continued until about month 46.⁶ Across cohort studies, clozapine was associated with a higher risk of type 2 diabetes than other second-generation antipsychotics, with a risk ratio of 1.78.⁷

A 2025 randomized trial tested semaglutide in 31 adults with schizophrenia who were taking clozapine and had a body mass index of 26 or higher. At 36 weeks, body weight fell by 13.9% with semaglutide and 0.4% with placebo. Clozapine blood levels and psychotic symptoms were unchanged.⁸ The trial was small and stopped recruiting early when the study drug became unavailable, so the result needs confirmation. Metformin and the other options are on the page about clozapine weight gain.

Seizures are dose-related

The label estimates a cumulative incidence of seizure of about 5% at one year, based on premarketing studies, and describes the risk as dose-related.² In a 2025 meta-analysis of randomized trials, seizures were more frequent with clozapine than with other antipsychotics, with a risk ratio of 3.61.⁹ The label recommends a low starting dose, slow titration, and divided doses.

Smoking, infections, and other medications change clozapine levels

Tobacco smoke speeds up the enzyme that clears clozapine. When someone stops smoking, clozapine levels can rise, and the label advises considering a dose reduction.² A hospital admission where smoking isn't allowed is one way this happens without anyone planning for it.

Case reports describe higher clozapine levels during pneumonia and other inflammatory illness, although the label notes the clinical significance isn't fully characterized. Fluvoxamine and ciprofloxacin strongly inhibit the same enzyme, and the label recommends reducing the clozapine dose to one third when either is added.² Patients should tell their psychiatrist before quitting smoking and whenever another doctor prescribes an antibiotic. Blood level ranges and timing are on the page about clozapine levels.

Sedation, drooling, and the everyday effects

Sedation, drooling, and a fast heart rate are among the most common adverse reactions in the label.² A global consensus panel in 2026 recommended that routine monitoring also cover bedwetting, reflux, sleep apnea, constipation, and metabolic syndrome.¹⁰ The treatment evidence for drooling is on the page about clozapine drooling.

What the randomized trials show overall

A 2025 meta-analysis pooled 116 randomized trials with 8,431 participants. In the 69 trials of clozapine alone, mortality did not differ between clozapine and other antipsychotics, and discontinuation because of adverse effects did not differ either. Clozapine was associated with more seizures, low blood pressure, sedation, drooling, and constipation.⁹ Blood count monitoring is covered on the page about clozapine blood tests.

Limitations of the evidence

These data have limitations. First, the long-term figures come from Finnish registers and may not generalize. Second, the myocarditis series relied on voluntary reports. Third, randomized trials are short and miss effects that take years to develop. Nevertheless, the pattern is consistent enough to plan around: cardiac and blood risks early, bowel and metabolic risks throughout.

Frequently asked questions

What is the most dangerous side effect of clozapine?

Severe neutropenia, myocarditis, seizures, and severe constipation leading to bowel obstruction can each be fatal. In a Finnish 25-year study, ileus and pneumonia were more frequent than previously reported and were both associated with higher mortality.^{2, 1}

How serious is constipation on clozapine?

It can progress to paralytic ileus, bowel obstruction, and perforation. The label recommends screening for constipation before starting, asking about bowel function frequently, and treating promptly with laxatives.²

When does clozapine myocarditis happen?

Mostly in the first two months. In an Australian series, every case of myocarditis occurred within three weeks of starting clozapine. Fever, chest pain, or shortness of breath in that period needs prompt evaluation.^{2, 3}

Does quitting smoking affect clozapine?

Yes. Tobacco smoke speeds up the enzyme that clears clozapine, so levels can rise when someone stops smoking. The label advises considering a dose reduction when smoking stops.²

Can semaglutide help with clozapine weight gain?

In one small randomized trial of 31 adults taking clozapine, body weight fell by 13.9% with semaglutide and 0.4% with placebo at 36 weeks, without changes in clozapine levels or psychotic symptoms. The result needs confirmation in larger trials.⁸

In a crisis: call or text 988, or go to the nearest emergency department. A first episode of psychosis belongs in a hospital-based or coordinated specialty care program.

I start and manage clozapine in an outpatient practice in Chelsea, Manhattan. Details are on the schizophrenia care in NYC page. Clozapine should not be stopped, skipped, or restarted without the prescriber. This page is general information and does not replace an evaluation.